Prediction of anti-CD25 and 5-FU treatments efficacy for pancreatic cancer using a mathematical model

por Sajad Shafiekhani, Hojat Dehghanbanadaki, Azam Sadat Fatemi, Sara Rahbar, Jamshid Hadjati, Amir Homayoun Jafari
Publicado 2021

CRISPR/Cas9-mediated TGFβRII disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells in vitro

por Khadijeh Alishah, Matthias Birtel, Elham Masoumi, Leila Jafarzadeh, Hamid Reza Mirzaee, Jamshid Hadjati, Ralf-Holger Voss, Mustafa Diken, Sedighe Asad
Publicado 2021